StonvexLoading…
StonvexStonvexStonvexCore line items from PRAX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $0.00 | $8.55M | $2.45M | $0.00 |
Operating Income | $-326.20M | $-200.16M | $-126.37M | $-214.99M |
Net Income | $-303.27M | $-182.82M | $-123.28M | $-214.03M |
EPS (Diluted) | $-13.48 | $-10.21 | $-18.69 | $-69.65 |
Total Assets | $937.91M | $483.11M | $87.95M | $115.13M |
Total Liabilities | $59.77M | $37.66M | $18.28M | $39.02M |
Cash & Equivalents | $357.33M | $215.37M | $81.30M | $61.62M |
Free Cash Flow OCF − CapEx | $-249.12M | $-131.76M | $-111.19M | $-185.49M |
Shares Outstanding | 25.20M | 19.42M | 8.79M | 3.29M |